Artera Launches AI Test for Decision-making on Prostate Cancer Treatment Course
Artera, the Los Altos, California-based developer of tools to diagnose cancer, has launched the first artificial intelligence [...]
Unlocking the Global Potential of Precision Medicine with AI
While the US has been a leader in precision medicine for cancer research and healthcare innovation, countries around the worl [...]
How AI Can Help Alleviate the Stress of a Cancer Diagnosis
In an era where cancer rates continue to rise, the emotional toll a cancer diagnosis and the subsequent treatment journey has [...]
What My Patients Have Taught Me During Their Cancer Journeys
As a radiation oncologist, I have the privilege of walking alongside my patients through their cancer journeys. While I certa [...]
ASCO 2024: Randomized PROSTATE-IQ Trial to Reduce ADT Treatment Burden for Patients with Biochemical Recurrence After Prostatectomy
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 31st and June 4th, 2024 [...]
How can Artera bootstrap a new AWS region within hours?
Setting up the infrastructure for a product line in an entirely new region with over 340 distinct AWS resources could easily [...]
Doctors Explain What Prostate Cancer Screenings Involve
If you've never had a prostate cancer screening, you may worry that it will be embarrassing and uncomfortable. Doctors say th [...]
ArteraAI Prostate Test Included in NCCN Guidelines
The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Prostate Cancer have included the ArteraAI [...]
Here’s how AI will drive health care to meet consumer expectations
The rapid transformation of the health care landscape is undeniable. It is marked not only by groundbreaking technologies and [...]